71°

Site search

Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Home
- Contact Us
- Subscribe
News
Sports
Features
Classifieds
Obituaries
Subscribe
E-Edition
Readers' Choice

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Matinas Biopharma Holdings, Inc. Common Stock (NY:MTNB)

2.730 -0.140 (-4.88%)

Delayed Quote Updated: 12:29 PM EDT, Oct 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Matinas Biopharma Holdings, Inc. Common Stock

< Previous 1 2 3 4 5 Next >

Is Next-Generation Drug Delivery Coming to a Hospital Near You? ↗

December 01, 2021

Photo by Anna Shvets on Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner...

Via Benzinga

On Target: This Company Says It Delivers Drugs Exactly How You Need Them ↗

November 15, 2021

Photo by Anna Shvets from Pexels The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

46 Biggest Movers From Yesterday ↗

October 12, 2021

Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares jumped 93.9% to close at $35.36 on Monday. The FDA removed the full clinical hold on Protagonist Therapeutics’...

Via Benzinga

Earnings Scheduled For August 10, 2021 ↗

August 10, 2021

Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Earnings Scheduled For May 10, 2021 ↗

May 10, 2021

Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report...

Via Benzinga

Earnings Scheduled For November 8, 2021 ↗

November 08, 2021

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •...

Via Benzinga

28 Stocks Moving In Monday's Mid-Day Session ↗

October 11, 2021

Gainers Protagonist Therapeutics, Inc. (NASDAQ: PTGX) shares surged 85% to $33.78. The FDA removed the full clinical hold on Protagonist Therapeutics’ rusfertide clinical...

Via Benzinga

15 Stocks Moving in Monday's Pre-Market Session ↗

October 11, 2021

Gainers Trevi Therapeutics, Inc. (NASDAQ: TRVI) rose 32.5% to $1.59 in pre-market trading after the company filed Friday to withdraw its offering of shares. Nutriband Inc. (...

Via Benzinga

16 Stocks Moving in Tuesday's Pre-Market Session ↗

October 05, 2021

Gainers Marine Petroleum Trust (NASDAQ: MARPS) rose 25.4% to $6.29 in pre-market trading after gaining 8% on Monday. Agrify Corporation. (NASDAQ: AGFY) rose 17.8% to $21.76 in...

Via Benzinga

16 Stocks Moving in Wednesday's Pre-Market Session ↗

September 29, 2021

Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) rose 29.7% to $5.42 in pre-market trading after the company reported the purchase of exclusive rights to PNP Therapeutics'...

Via Benzinga

24 Stocks Moving in Thursday's Pre-Market Session ↗

September 23, 2021

Gainers Amplitude Healthcare Acquisition Corporation (NASDAQ: AMHC) rose 61.8% to $16.55 in pre-market trading. The company disclosed that shareholders approved the business...

Via Benzinga

46 Biggest Movers From Yesterday ↗

September 15, 2021

Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share. Onion Global Limited...

Via Benzinga

Why Matinas BioPharma's Stock Is Trading Higher Today ↗

September 14, 2021

Matinas BioPharma Hldgs (AMEX:MTNB) shares are trading higher on continued upward momentum after the company yesterday announced data in the ongoing EnACT trial of MAT2203...

Via Benzinga

36 Stocks Moving In Tuesday's Mid-Day Session ↗

September 14, 2021

Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results. BELLUS Health Inc. (NASDAQ: BLU) shares...

Via Benzinga

20 Stocks Moving in Tuesday's Pre-Market Session ↗

September 14, 2021

Gainers Communications Systems, Inc. (NASDAQ: JCS) rose 34.8% to $9.15 in pre-market trading as the company declared a special dividend of $3.50 per share. DatChat, Inc. (NASDAQ...

Via Benzinga

Matinas BioPharma Stock Jumps After Meningitis Candidate Data ↗

September 13, 2021

Matinas BioPharma Holdings Inc (NYSE: MTNB) has announced positive data from the first two cohorts of the Phase 2 EnACT trial of MAT2203 (oral amphotericin B) for...

Via Benzinga

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts ↗

August 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

Matinas BioPharma Hldgs Earnings Preview ↗

August 09, 2021

Matinas BioPharma Hldgs (AMEX:MTNB) announces its next round of earnings this Tuesday, August 10. Here is Benzinga's everything-that-matters guide for this Tuesday's Q2 earnings...

Via Benzinga

Matinas BioPharma Hldgs: Return On Capital Employed Insights ↗

June 23, 2021

Matinas BioPharma Hldgs (AMEX:MTNB) reported Q1 sales of $33.33 thousand. Earnings fell to a loss of $6.35 million, resulting in a 2.09% decrease from last quarter. Matinas...

Via Benzinga

Return On Capital Employed Overview: Matinas BioPharma Hldgs ↗

June 07, 2021

Matinas BioPharma Hldgs (AMEX:MTNB) reported Q1 sales of $33.33 thousand. Earnings fell to a loss of $6.35 million, resulting in a 2.09% decrease from last quarter. In Q4, Matinas...

Via Benzinga

Matinas BioPharma Hldgs's Earnings: A Preview ↗

May 07, 2021

Matinas BioPharma Hldgs (AMEX:MTNB) announces its next round of earnings this Monday, May 10. Here is Benzinga's everything-that-matters guide for this Monday's Q1 earnings...

Via Benzinga

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard Times

Services

Contact Us
Subscription Services
Promote Your Event
Site Forms
Search

ricentral.com
187 Main Street
Wakefield, RI 02879
Phone: 401-789-9744
Email: news@ricentral.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Matinas Biopharma Holdings, Inc. Common Stock (NY:MTNB)

All News about Matinas Biopharma Holdings, Inc. Common Stock

Sections

Services